Mycobacterium Citations List: February, 2016

Literature Citations

1. Fused Heterocycles: Synthesis and Antitubercular Activity of Novel 6-Substituted-2-(4-methyl-2-substituted phenylthiazol-5-yl)H-imidazo[1,2-a]Pyridine. Abhale, Y.K., K.K. Deshmukh, A.V. Sasane, A.P. Chavan, and P.C. Mhaske. Journal of Heterocyclic Chemistry, 2016. 53(1): p. 229-233. ISI[000369003300030].

[WOS]. TB_02_2016.

2. Fluoroquinolone Interactions with Mycobacterium tuberculosis Gyrase: Enhancing Drug Activity against Wild-type and Resistant Gyrase. Aldred, K.J., T.R. Blower, R.J. Kerns, J.M. Berger, and N. Osheroff. Proceedings of the National Academy of Sciences of the United States of America, 2016. 113(7): p. 839-846. PMID[26792518]. PMCID[PMC4763725].

[PubMed]. TB_02_2016.

3. Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-beta-D-ribose Oxidase. Batt, S.M., M.C. Izquierdo, J.C. Pichel, C.J. Stubbs, L.V.G. Del Peral, E. Perez-Herran, N. Dhar, B. Mouzon, M. Rees, J.P. Hutchinson, R.J. Young, J.D. McKinney, D.B. Aguirre, L. Ballell, G.S. Besra, and A. Argyrou. ACS Infectious Diseases, 2015. 1(12): p. 615-626. ISI[000368464400007].

[WOS]. TB_02_2016.

4. Some Novel Schiff Bases of 1,2,4 Triazole Bearing Haloarene Moiety-synthesis and Evaluation of Antituberculosis Properties and Neutrophil Function Test. Castelino, P.A., J.P. Dasappa, K.G. Bhat, S.A. Joshi, and S. Jalalpure. Medicinal Chemistry Research, 2016. 25(1): p. 83-93. ISI[000368548500008].

[WOS]. TB_02_2016.

5. Evaluation of Anti-tubercular Activity of Linolenic acid and Conjugated-linoleic acid as Effective Inhibitors against Mycobacterium tuberculosis. Choi, W.H. Asian Pacific Journal of Tropical Medicine, 2016. 9(2): p. 125-129. PMID[26919940].

[PubMed]. TB_02_2016.

6. Synthesis and Anti-tuberculosis Activity of Glycitylamines. Corkran, H.M., E.M. Dangerfield, G.W. Haslett, B.L. Stocker, and M.S. Timmer. Bioorganic & Medicinal Chemistry, 2016. 24(4): p. 693-702. PMID[26810833].

[PubMed]. TB_02_2016.

7. Synthesis and Biological Evaluation of 1,3,4-Oxadiazole Bearing Dihydropyrimidines as Potential Antitubercular Agents. Desai, N.C., A.R. Trivedi, H.V. Vaghani, H.C. Somani, and K.A. Bhatt. Medicinal Chemistry Research, 2016. 25(2): p. 329-338. ISI[000368548800012].

[WOS]. TB_02_2016.

8. Antimycobacterial Activity against Different Pathogens and Selectivity Index of Fourteen Medicinal Plants Used in Southern Africa to Treat Tuberculosis and Respiratory Ailments. Dzoyem, J.P., A.O. Aro, L.J. McGaw, and J.N. Eloff. South African Journal of Botany, 2016. 102: p. 70-74. ISI[000368959100011].

[WOS]. TB_02_2016.

9. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin. Ferro, B.E., J. Meletiadis, M. Wattenberg, A. de Jong, D. van Soolingen, J.W. Mouton, and J. van Ingen. Antimicrobial Agents and Chemotherapy, 2016. 60(2): p. 1097-1105. PMID[26643335]. PMCID[PMC4750661].

[PubMed]. TB_02_2016.

10. Nordihydroguaiaretic acid (NDGA) and alpha-Mangostin Inhibit the Growth of Mycobacterium tuberculosis by Inducing Autophagy. Guzman-Beltran, S., M.A. Rubio-Badillo, E. Juarez, F. Hernandez-Sanchez, and M. Torres. International Immunopharmacology, 2016. 31: p. 149-157. PMID[26735610].

[PubMed]. TB_02_2016.

11. Identification of a Novel Class of Quinoline-Oxadiazole Hybrids as Anti-tuberculosis Agents. Jain, P.P., M.S. Degani, A. Raju, A. Anantram, M. Seervi, S. Sathaye, M. Ray, and M.G.R. Rajan. Bioorganic & Medicinal Chemistry Letters, 2016. 26(2): p. 645-649. PMID[26675440].

[PubMed]. TB_02_2016.

12. New Pimarane Diterpenes and Other Antimycobacterial Metabolites from Anisochilus verticillatus. Kulkarni, R.R., K. Shurpali, V.M. Khedkar, V.G. Puranik, D. Sarkar, and S.P. Joshi. Natural Product Research, 2016. 30(6): p. 675-681. PMID[25978136].

[PubMed]. TB_02_2016.

13. A Focused Screen Identifies Antifolates with Activity on Mycobacterium tuberculosis. Kumar, A., A. Guardia, G. Colmenarejo, E. Perez, R.R. Gonzalez, P. Torres, D. Calvo, R.M. Gomez, F. Ortega, E. Jimenez, R.C. Gabarro, J. Rullas, L. Ballell, and D.R. Sherman. ACS Infectious Diseases, 2015. 1(12): p. 604-614. ISI[000368464400006].

[WOS]. TB_02_2016.

14. Inhibiting the beta-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic acid Transition-state Inhibitors (BATSIs). Kurz, S.G., S. Hazra, C.R. Bethel, C. Romagnoli, E. Caselli, F. Prati, J.S. Blanchard, and R.A. Bonomo. ACS Infectious Diseases, 2015. 1(6): p. 234-242. ISI[000368463600002].

[WOS]. TB_02_2016.

15. Convenient Synthesis of Novel Quinazoline Congeners via Copper Catalyzed C-N/C-S Coupling and Their Biological Evaluation. Lakum, H.P., D.R. Shah, and K.H. Chikhalia. Journal of Heterocyclic Chemistry, 2016. 53(1): p. 209-219. ISI[000369003300028].

[WOS]. TB_02_2016.

16. Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity. Landge, S., V. Ramachandran, A. Kumar, J. Neres, K. Murugan, C. Sadler, M.D. Fellows, V. Humnabadkar, P. Vachaspati, A. Raichurkar, S. Sharma, S. Ravishankar, S. Guptha, V.K. Sambandamurthy, T.S. Balganesh, B.G. Ugarkar, V. Balasubramanian, B.S. Bandodkar, and M. Panda. ChemMedChem, 2016. 11(3): p. 331-339. PMID[26751718].

[PubMed]. TB_02_2016.

17. Diaza-anthracene Antibiotics from a Freshwater-derived Actinomycete with Selective Antibacterial Activity toward Mycobacterium tuberculosis. Mullowney, M.W., C.H. Hwang, A.G. Newsome, X.W. Wei, U. Tanouye, B.J. Wan, S. Carlson, N.J. Barranis, E.O. hAinmhire, W.L. Chen, K. Krishnamoorthy, J. White, R. Blair, H. Lee, J.E. Burdette, P.K. Rathod, T. Parish, S. Cho, S.G. Franzblau, and B.T. Murphy. ACS Infectious Diseases, 2015. 1(4): p. 168-174. ISI[000368463400003].

[WOS]. TB_02_2016.

18. Synthesis, in Vitro Antimycobacterial Evaluation and Docking Studies of Some New 5,6,7,8-Tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one Schiff Bases. Narender, M., S.B. Jaswanth, K. Umasankar, J. Malathi, A. Raghuram Reddy, K.R. Umadevi, A.V. Dusthackeer, K. Venkat Rao, and R.A. Raghuram. Bioorganic & Medicinal Chemistry Letters, 2016. 26(3): p. 836-840. PMID[26755393].

[PubMed]. TB_02_2016.

19. Structure and Activity Relationships of the Anti-mycobacterium Antibiotics Resorcinomycin and Pheganomycin. Ogasawara, Y., K. Ooya, M. Fujimori, M. Noike, and T. Dairi. Journal of Antibiotics, 2016. 69(2): p. 119-120. PMID[26306817].

[PubMed]. TB_02_2016.

20. Rational Design and Synthesis of Substrate-product Analogue Inhibitors of alpha-Methylacyl-coenzyme A Racemase from Mycobacterium tuberculosis. Pal, M., M. Khanal, R. Marko, S. Thirumalairajan, and S.L. Bearne. Chemical Communications, 2016. 52(13): p. 2740-2743. PMID[26759836].

[PubMed]. TB_02_2016.

21. Design and Development of Mycobacterium tuberculosis Lysine epsilon-Aminotransferase Inhibitors for Latent Tuberculosis Infection. Parthiban, B.D., S. Saxena, M. Chandran, P.S. Jonnalagadda, R. Yadav, R.R. Srilakshmi, Y. Perumal, and S. Dharmarajan. Chemical Biology & Drug Design, 2016. 87(2): p. 265-274. PMID[26348876].

[PubMed]. TB_02_2016.

22. Synthesis and Bioactivity of Antitubercular Peptides and Peptidomimetics: An Update. Rodriguez, L.M.D., H. Kaur, and M.A. Brimble. Organic & Biomolecular Chemistry, 2016. 14(4): p. 1177-1187. PMID[26645944].

[PubMed]. TB_02_2016.

23. Synthesis and Anti-tubercular Activity of N(2)-Arylbenzo[g]isoquinoline-5,10-dione-3-iminium bromides. Rotthier, G., D. Cappoen, Q.T. Nguyen, T.A. Dang Thi, V. Mathys, V.T. Nguyen, K. Huygen, L. Maes, P. Cos, and K. Abbaspour Tehrani. Organic & Biomolecular Chemistry, 2016. 14(6): p. 2041-2051. PMID[26763748].

[PubMed]. TB_02_2016.

24. Synthesis of New Spirooxindole Derivatives through 1,3-Dipolar Cycloaddition of Azomethine ylides and Their Antitubercular Activity. Rouatbi, F., M. Askri, F. Nana, G. Kirsch, D. Sriram, and P. Yogeeswari. Tetrahedron Letters, 2016. 57(2): p. 163-167. ISI[000368967800001].

[WOS]. TB_02_2016.

25. Design, Synthesis and Biological Evaluation of Imidazo[2,1-b]thiazole and Benzo[d]imidazo[2,1-b]thiazole Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors. Samala, G., P.B. Devi, S. Saxena, N. Meda, P. Yogeeswari, and D. Sriram. Bioorganic & Medicinal Chemistry, 2016. 24(6): p. 1298-1307. PMID[26867485].

[PubMed]. TB_02_2016.

26. Novel Benzimidazole-oxadiazole Hybrid Molecules as Promising Antimicrobial Agents. Shruthi, N., B. Poojary, V. Kumar, M.M. Hussain, V.M. Rai, V.R. Pai, M. Bhat, and B.C. Revannasiddappa. RSC Advances, 2016. 6(10): p. 8312-8325. ISI[000369515700073].

[WOS]. TB_02_2016.

27. Development of an Intracellular Screen for New Compounds Able to Inhibit Mycobacterium tuberculosis Growth in Human Macrophages. Sorrentino, F., R.G. del Rio, X. Zheng, J.P. Matilla, P.T. Gomez, M.M. Hoyos, M.E.P. Herran, A.M. Losana, and Y. Av-Gay. Antimicrobial Agents and Chemotherapy, 2016. 60(1): p. 640-645. ISI[000369154600083].

[WOS]. TB_02_2016.

28. Comparative Analyses of the Proteins from Mycobacterium tuberculosis and Human Genomes: Identification of Potential Tuberculosis Drug Targets. Sridhar, S., P. Dash, and K. Guruprasad. Gene, 2016. 579(1): p. 69-74. PMID[26762852].

[PubMed]. TB_02_2016.

29. Synthesis and Antituberculosis Activity of Indole-pyridine Derived Hydrazides, Hydrazide-hydrazones, and Thiosemicarbazones. Velezheva, V., P. Brennan, P. Ivanov, A. Kornienko, S. Lyubimov, K. Kazarian, B. Nikonenko, K. Majorov, and A. Apt. Bioorganic & Medicinal Chemistry Letters, 2016. 26(3): p. 978-985. PMID[26725953].

[PubMed]. TB_02_2016.

30. Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-molecule Library against Nonreplicating Mycobacterium tuberculosis. Warrier, T., M. Martinez-Hoyos, M. Marin-Amieva, G. Colmenarejo, E. Porras-De Francisco, A.I. Alvarez-Pedraglio, M.T. Fraile-Gabaldon, P.A. Torres-Gomez, L. Lopez-Quezada, B. Gold, J. Roberts, Y. Ling, S. Somersan-Karakaya, D. Little, N. Cammack, C. Nathan, and A. Mendoza-Losana. ACS Infectious Diseases, 2015. 1(12): p. 580-585. ISI[000368464400003].

[WOS]. TB_02_2016.

31. In Vitro Activity of beta-Lactams in Combination with beta-Lactamase Inhibitors against Multidrug-resistant Mycobacterium tuberculosis Isolates. Zhang, D., Y.F. Wang, J. Lu, and Y. Pang. Antimicrobial Agents and Chemotherapy, 2016. 60(1): p. 393-399. PMID[26525785]. PMCID[PMC4704149].

[PubMed]. TB_02_2016.

Patent Citations

32. Preparation of Tricycles as Antibacterial Agents. Ratcliffe, A., I. Cooper, M. Pichowicz, N. Stokes, and C. Charrier. Patent. 2016. 2015-GB52303 2016024096: 143pp.

[Patent]. TB_02_2016.

33. Application of Cyanogramide in Preparation of anti-TB Drugs. Tian, L. Patent. 2016. 2015-10761826 105250270: 6pp.

[Patent]. TB_02_2016.